Efficacy of satralizumab in subgroups of patients in SAkuraSky: A phase III double-blind, placebo-controlled, add-on study in patients with neuromyelitis optica spectrum disorder (NMOSD)

Saved in:
Bibliographic Details
Published in:Journal of the neurological sciences 2019-10, Vol.405, p.11-12
Main Authors: Yamamura, T., Kleiter, I., Fujihara, K., Palace, J., Greenberg, J., Zakrzewska-Pniewska, B., Patti, F., Tsai, C.P., Saiz, A., Haramura, M., Terada, Y., Kawata, Y., De Seze, J.
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0022-510X
1878-5883
DOI:10.1016/j.jns.2019.10.231